HOME > 研究業績 > 2016年- 英語論文

2016年- 英語論文

1. Harada R, Okamura N, Furumoto S, Tago T, Yanai K, Arai H, Kudo Y. Characteristics of Tau and Its Ligands in PET Imaging. Biomolecules. 2016 Jan 6;6(1). pii: E7. doi: 10.3390/biom6010007. Review.

2. Michio Hashimoto, Shahdat Hossain, Abdullah Al Mamun, Kenta Matsuzaki & Hiroyuki Arai Docosahexaenoic acid: one molecule diverse Functions Critical Reviews in Biotechnology DOI:10.1080/07388551. 2016.1207153

3. Harada R, Okamura N, Furumoto S, Furukawa K, Ishiki A, Tomita N, Tago T, Hiraoka K, Watanuki S, Shidahara M, Miyake M, Ishikawa Y, Matsuda R, Inami A, Yoshikawa T, Funaki Y, Iwata R, Tashiro M, Yanai K, Arai H, Kudo Y. 18F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer's Disease. J Nucl Med. 2016 Feb vol.57 jnumed.115.164848. [Epub ahead of print]

4.  Ishiki A, Kamada M, Kawamura Y, Terao C, Shimada F, Tomita N, Arai H, Furukawa K. Glial fibrillar acidic protein in the cerebrospinal fluid of Alzheimer’s disease, dementia with Lewy bodies, and frontotemporal lobar degeneration. J. Neurochem. 2016 Jan 136(2):258-61 DOI:10.1111/jnc 13999

5. Yamashita S, Kiko T, Fujiwara H, Hashimoto M, Nakagawa K, Kinoshita M, Furukawa K, Arai H, Miyazawa T. Alterations in the Levels of Amyloid-β, Phospholipid Hydroperoxide, and Plasmalogen in the Blood of Patients with Alzheimer's Disease: Possible Interactions between Amyloid-β and These Lipids. J Alzheimers Dis. 2016;50(2):527-37. doi: 10.3233/JAD-150640.


6. Okamura N, Harada R, Furukawa K, Furumoto S, Tago T, Yanai K, Arai H, Kudo Y  Advances in the Development of Tau PET Radiotracers and Their Clinical Applications. Ageing Res Rev. 2016 Sep. 30:107-13 doi: 10.1016/j.arr.2015.12.010. [Epub ahead of print]

7. Aiko Ishiki, Katsutoshi Furukawa, Hiroyuki Arai, et al. Changes in Cognitive Functions in the Elderly Living in Temporary Housing after the Great East Japan Earthquake. PLoS  One. 2016 Jan 13;11(1):e0147025. doi: 10.1371/journal.pone.0147025.

8. Sekiyama K, Takamatsu Y, Koike W, Waragai M, Takenouchi T, Sugama S, Hashimoto M. Insight into the Dissociation of Behavior from Histology in Synucleinopathies and in Related Neurodegenerative Diseases. J Alzheimers Dis. 2016 Mar 31;52(3):831-41. doi: 10.3233/JAD-151015

9. Yoshihara A, Fukatsu M, Hoshi K, Ito H, Nollet K, Yamaguchi Y, Ishii R, Tokuda T, Miyajima M, Arai H, Kato T, Furukawa K, Arai H, Kikuchi A, Takeda A, Ugawa Y, Hashimoto Y. Subgroup differences in 'brain-type' transferrin and α-synuclein in Parkinson's disease and multiple system atrophy. J Biochem. 2016 Aug;160(2):87-91. doi: 10.1093/jb/mvw015.

10. Hasegawa K, Tagawa M, Takagi K, Tsukamoto H, Tomioka Y, Suzuki T, Nishioka Y, Ohrui T and Nimasaki M. Anti-tumor immunity elicited by direct intratumoral administration of a recombinant adenovirus expressing either IL-28A/IFN-λ2 or IL-29/IFN-λ1. Cencer Cene Therapy 2016 Aug;23(8):266-77. doi: 10.1038/cgt.2016.29. Epub 2016 Aug 19.

11. Numasaki M, Tsukamoto H, Tomioka Y, Nishioka Y, Ohrui T. A heterodimeric cytokine, consisting of IL-17A and IL-17F, promotes migration and Capillary-like tube formation of human cascular endothelial cells. Tohoku J Exp. Med. 2016;240(1):47-56. doi: 10.1620/tjem.240.47.

12. Harada R, Furumoto S, Tago T, Furukawa K, Ishiki A, Tomita N, Iwata R, Tashiro M, Arai H, Kudo Y, Okamura N. “Characterization of the radiolabeled metabolite of tau PET tracer 18F-THK5351”. European Journal of Nuclear Medicine and Molecular Imaging, Springer. 2016 Nov;43(12):2211-2218, DOI: 10.1007/s00259-016-3453-y

13. Lockhart SN, Baker SL, Okamura N, Furukawa K, Ishiki A, Furumoto S, Tashiro M, Yanai K, Arai H, Kudo Y, Harada R, Tomita N, Hiraoka K, Watanuki S, Jagust WJ. “Dynamic PET Measures of Tau Accumulation in Cognitively Normal Older Adults and Alzheimer’s Disease Patients Measured Using [18F]THK-5351” . PLos One. 2016 Jun 29;11(6):e0158460. doi: 10.1371/journal.pone.0158460. eCollection 2016.

14. Ishiki A, Okinaga S, Tomita N, Kawahara R, Tsuji I, Nagatomi R, Taki Y, Takahashi T, Kuzuya M, Morimoto S, Iijima K, Koseki T, Arai H, Furukawa K. Changes in Cognitive Functions in the Elderly Living in Temporary Housing after the Great East Japan Earthquake. PLoS One. 2016 Jan 13;11(1):e0147025. doi: 10.1371/journal.pone.0147025.

15. Furukawa K, Ishiki A, Tomita N, Onaka Y, Saito H, Nakamichi T, Hara K, Kusano Y, Ebara M, Arata Y, Sakota M, Miyazawa I, Totsune T, Okinaga S, Okamura N, Kudo Y, Arai H. Introduction and overview of the special issue "Brain imaging and aging": The new era of neuroimaging in aging research. Ageing Res Rev. 2016 Sep;30:1-3. doi: 10.1016/j.arr.2016.02.005.

16. Ishiki A, Arai H, Furukawa K, et al.  Tau imaging with [18 F]THK-5351 in progressive supranuclear palsy. Eur J Neurol. 2017 Jan;24(1):130-136. doi: 10.1111/ene.13164.

17. Suzuki H, Matsumoto Y, Ota H, Sugimura K, Takahashi J, Ito K, Miyata S, Furukawa K, Arai H, Fukumoto Y, Taki Y, Shimokawa H. Hippocampal Blood Flow Abnormality Associated With Depressive Symptoms and Cognitive Impairment in Patients With Chronic Heart Failure. Circ J. 2016 Jul 25;80(8):1773-80. doi: 10.1253/circj.CJ-16-0367. Epub 2016 Jun 7.

18. Waragai M, Adame A, Trinh I, Sekiyama K, Takamatsu Y, Une K, Masliah E, Hashimoto M. Possible Involvement of Adiponectin, the Anti-Diabetes Molecule, in the Pathogenesis of Alzheimer's Disease. J Alzheimers Dis. 2016 Apr 8;52(4):1453-9. doi: 10.3233/JAD-151116.

19. Kikuchi A, Okamura N, Hasegawa T, Harada R, Watanuki S, Funaki Y, Hiraoka K, Baba T, Sugeno N, Oshima R, Yoshida S, Kobayashi J, Ezura M, Kobayashi M, Tano O, Mugikura S, Iwata R, Ishiki A, Furukawa K, Arai H, Furumoto S, Tashiro M, Yanai K, Kudo Y, Takeda A, Aoki M. In vivo visualization of tau deposits in corticobasal syndrome by 18F-THK5351 PET. Neurology. 2016 Nov 29;87(22):2309-2316. Epub 2016 Oct 28.

20. Hashimoto M, Inoue T, Katakura M, Hossain S, Mamun AA, Matsuzaki K, Arai H, Shido O. Differential effects of docoosahexaenoic and arachidonic acid on fatty acid composition and myosin heavy chain-related genes of slow- and fast-twitch skeletal muscle tissues. Mol Cell Biochem. 2016 Apr;415(1-2):169-81. doi: 10.1007/s11010-016-2689-y. Epub 2016 Mar 28.

21. Kojima T, Mizukami K, Tomita N, Arai H, Ohrui T, Eto M, Takeya Y, Isaka Y, Rakugi H, Sudo N, Arai H, Aoki H, Horie S, Ishii S, Iwasaki K, Takayama S, Suzuki Y, Matsui T, Mizokami F, Furuta K, Toba K, Akishita M. Report of the committee: Screening Tool for Older Persons’ Appropriate Prescriptions in Japanese (STOPP-J) ? Report of the Japan Geriatrics Society Working Group on “Guidelines for Medical Treatment and its Safety in the Elderly. Geriatr Gerontol Int. 2016 Sep;16(9):983-1001. doi: 10.1111/ggi.12890.

22. Otoki Y, Kato S, Kimura F, Furukawa K, Yamashita S, Arai H, Miyazawa T, Nakagawa K. Accurate quantitation of choline and ethanolamine plasmalogen molecular species in human plasma by liquid chromatography-tandem mass spectrometry. J Pharm Biomed Anal. 2017 Feb 5;134:77-85. doi: 10.1016/j.jpba.2016.11.019. Epub 2016 Nov 15.

23. Numasaki M, Tagawa M, Tsukamoto H, Tomioka Y, Ohrui T and Arai H. Immunogenetherapy of cancer using recombinant adenovirus expressing Type III interferon IL-28 or IL-29. Immunotherapy (Los Angel). 2016. 2. 131 DOI:10.4172/2471-9552.1000131.